A new lawsuit accuses transvaginal mesh manufacturer Boston Scientific of smuggling counterfeit pelvic mesh from China. Boston Scientific is charged with intentionally defrauding and endangering women by secretly importing defective polypropylene resin that wasn’t approved by the FDA.… Read More


Using the diabetes drug Actos for one year or more increases the risk of being diagnosed with bladder cancer by 39% according reports reviewed by the FDA in 2011. Even though the diabetes drug Actos (generic name: pioglitazone) has been taken off the market by the drug regulators of Germany, France, and India because of safety concerns, The Food and Drug Administration (FDA), despite issuing several safety communications about the drug, still allows Actos to be marketed in the United States. The FDA continues to evaluate the data.… Read More


Posted by Marilyn McGoldrick on Feb 3, 2014 3:32:00 PM On Friday, the federal judge overseeing the Ethicon transvaginal mesh (TVM) litigation ruled that Johnson & Johnson (J&J) and its subsidiary, Ethicon, will not be allowed to introduce evidence that the FDA had previously approved surgical sutures made out of the same polypropylene used in Gynecare… Read More


A second DePuy ASR hip implant case scheduled for trial this month has been resolved, according to court records. The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.

The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.… Read More


Posted by Thornton Law Firm LLP on Sep 3, 2013 5:58:00 AM The first bellwether trial in the federal court Multi-District Litigation over Johnson & Johnson’s DePuy Unit’s metal hip implants is scheduled to begin on Monday, September 9, 2013. The plaintiff is Ann McCracken, a woman from Rochester, New York who underwent a DePuy… Read More


C.R. Bard recently settled the second federal Avaulta transvaginal mesh bellwether case just before trial which was scheduled to start last week. The settlement terms between Bard and the plaintiff, a North Carolina woman named Wanda Queen, are undisclosed. The announcement was made by U.S. District Court Judge Joseph R. Goodwin, who presides over all six surgical mesh consolidated federal multi-district litigation (MDL) dockets. Besides the Bard consolidated cases, Judge Goodwin presides over litigation involving American Medical Systems, Inc., Boston Scientific Corp., Coloplast Corp., Cook Medical, Inc., and Ethicon, Inc.… Read More


On August 15, 2013, a West Virginia jury awarded Donna Cisson a $2 million verdict, $250,000 in compensatory damages and $1.75 million in punitive damages, against C. R. Bard for injuries caused by its transvaginal mesh implant Avaulta. Donna Cisson’s attorneys presented evidence that her vaginal mesh implant caused bleeding, constant intractable pain and bladder spasms. Ultimately Cisson endured several surgeries to remove much of the surgical mesh; she still has 22 inches of mesh inside her body and the constant pain.… Read More